Publication | Closed Access

Metformin induces microRNA-34a to downregulate the Sirt1/Pgc-1α/Nrf2 pathway, leading to increased susceptibility of wild-type p53 cancer cells to oxidative stress and therapeutic agents

Sirt1/pgc-1α/nrf2 PathwayRadiation OncologyMedicineCancer Cell BiologyCell DeathMicrorna DetectionTumor SuppressorMetabolic SignalingCancer BiologyCell BiologyTherapeutic AgentsCancer ResearchOxidative Stress